DGAP-Stimmrechte: RHÖN-KLINIKUM AG (english)
RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG[the German Securities Trading Act] with the objective of Europe-wide
distribution
RHÖN-KLINIKUM AG
03.07.2012 15:00
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification according to section 26 para. 1 WpHG
On 2 July 2012, Credit Suisse Group AG, Zürich, Switzerland, Credit Suisse
AG, Zürich, Switzerland, Credit Suisse Investments (UK), London, UK, Credit
Suisse Investment Holdings (UK), London, UK, and Credit Suisse Securities
(Europe) Limited, London, UK, notified us pursuant to section 21 para. 1
WpHG of the following:
1) On 26 June 2012, Credit Suisse Group AG exceeded the threshold of 3% of
the voting rights in RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Credit Suisse Group AG held 3.19% of
the voting rights in RHÖN-KLINIKUM AG arising from 4,409,756 voting rights.
Of these voting rights, a proportion of 3.02% (equals 4,174,476 voting
rights) is attributed to Credit Suisse Group AG pursuant to section 22
para. 1 sent. 1 no. 1 WpHG (names of controlled undertakings: Credit Suisse
AG, Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK),
Credit Suisse Securities (Europe) Limited) and a proportion of 0.17%
(equals 235,280 voting rights) is attributed to Credit Suisse Group AG
pursuant to section 22 para. 1 sent. 1 no. 6 in connection with sent. 2
WpHG.
2) On 26 June 2012, Credit Suisse AG exceeded the threshold of 3% of the
voting rights in RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d.
Saale, Germany. On that date, Credit Suisse AG held 3.19% of the voting
rights in RHÖN-KLINIKUM AG arising from 4,409,756 voting rights.
Of these voting rights, a proportion of 0.0003% (equals 408 voting rights)
is held directly. A proportion of 3.02% (equals 4,174,068 voting rights) is
attributed to Credit Suisse AG pursuant to section 22 para. 1 sent. 1 no. 1
WpHG (names of controlled undertakings: Credit Suisse Investments (UK),
Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe)
Limited) and a proportion of 0.17% (equals 235,280 voting rights) is
attributed to Credit Suisse AG pursuant to section 22 para. 1 sent. 1 no. 6
in connection with sent. 2 WpHG.
3) On 26 June 2012, Credit Suisse Investments (UK) exceeded the threshold
of 3% of the voting rights in RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad
Neustadt a. d. Saale, Germany. On that date, Credit Suisse Investments (UK)
held 3.02% of the voting rights in RHÖN-KLINIKUM AG arising from 4,174,068
voting rights.
Of these voting rights, a proportion of 3.02% (equals 4,174,068 voting
rights) is attributed to Credit Suisse Investments (UK) pursuant to section
22 para. 1 sent. 1 no. 1 WpHG (names of controlled undertakings: Credit
Suisse Investment Holdings (UK), Credit Suisse Securities (Europe)
Limited).
4) On 26 June 2012, Credit Suisse Investment Holdings (UK) exceeded the
threshold of 3% of the voting rights in RHÖN-KLINIKUM AG, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, Credit Suisse
Investment Holdings (UK) held 3.02% of the voting rights in RHÖN-KLINIKUM
AG arising from 4,174,068 voting rights.
Of these voting rights, a proportion of 3.02% (equals 4,174,068 voting
rights) is attributed to Credit Suisse Investment Holdings (UK) pursuant to
section 22 para. 1 sent. 1 no. 1 WpHG (name of controlled undertaking:
Credit Suisse Securities (Europe) Limited).
5) On 26 June 2012, Credit Suisse Securities (Europe) Limited exceeded the
threshold of 3% of the voting rights in RHÖN-KLINIKUM AG, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, Credit Suisse
Securities (Europe) Limited held 3.02% of the voting rights in
RHÖN-KLINIKUM AG arising from 4,174,068 voting rights.
Bad Neustadt a.d. Saale, 3 July 2012
The Board of Management
________________________________________________________________
Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736
03.07.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Weitere Informationen: www.dpa-AFX.de
